Sometimes I think of RVNC, given that you'll probably be a lot more glabellar lines caused by stress, but then if everybody's staying further away from each other they'll be less noticeable...
There might be some tradable positions here, but I think the market still has room on the downside. I hear too many people still writing this off as overblown and don't understand the scope of the disease or the level of social distancing that is going to have to happen.
Dew, not me. I sold some ENTA yesterday and tried to sell some TRIL and EXEL also but was a bit too optimistic as to what price I could get. I also came close to selling my FTSV as it was some $2 below the GILD buyout price but figured I would hold tight on that.
Sadly, I don't see a bottom yet. As testing ramps up we will finally begin to get a handle on the extent of the COVID-19 spread, then more draconian efforts to control further spread will be asked for or mandated. A sad and worrisome day for sure.
NuGenerex Immuno-Oncology (NGIO) has filed the initial public filing of a Form 10.
SEC Form 10 is a filing with the Securities and Exchange Commission (SEC), also known as the General Form for Registration of Securities. It is used to register a class of securities for potential trading on U.S. exchanges. Any company with over $10 million in total assets and 750 or more shareholders is required to file a Form 10 with the SEC. Any company under these thresholds may file a Form 10 voluntarily. The Form 10 registration statement automatically becomes effective sixty days post-filing.